Dr. Lew Lim
Lew Lim, PhD, DNM, MBA, FCMA, is a globally recognized leader in photobiomodulation (PBM), specializing in brain function and the immune system. As Vielight’s Founder and CEO, and the architect of its extensive research ecosystem, he drives innovative PBM studies, spanning foundational neuroscience to applications in Alzheimer’s disease, long COVID, traumatic brain injury, amongst others.
Dr. Lim’s expertise spans neuroscience, engineering, natural medicine, business, and accountancy. He holds degrees from the University of California, Berkeley, Duke University, the University of Sheffield, and Quantum University.
About Vielight
Vielight Inc. is a global leader in transcranial photobiomodulation (tPBM), a wellness technology that uses safe, low-level near-infrared light to stimulate brain function and support neurological health.
Vielight develops patented, non-invasive devices designed for home use that deliver targeted light therapy to the brain. With over 100,000 devices sold worldwide, these systems boost cognition, memory, and focus while promoting cellular energy production and supporting recovery from neurological challenges.
Vielight's technology is featured in peer-reviewed scientific studies and trusted by individuals seeking mental clarity, elite athletes recovering from head injuries, healthcare professionals, and researchers worldwide. Learn more at www.vielight.com.
Light and Brain Injury: New Insights and Emerging Evidence for Photobiomodulation
March 22, 2025 1:00 pm ET